Immunogenicity of a 26-Valent Group A Streptococcal Vaccine
A multivalent vaccine containing amino-terminal M protein fragments from 26 different serotypes of group A streptococci was constructed by recombinant techniques. The vaccine consisted of four different recombinant proteins that were formulated with alum to contain 400 μg of protein per dose. Rabbit...
Guardat en:
| Publicat a: | Infect Immun |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Microbiology (ASM)
2002
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC127884/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11895984/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/IAI.70.4.2171-2177.2002 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|